Preventive Care

NIH-Developed Antibodies Neutralize HIV in Animal Studies

January 19, 2024 - On January 17, 2024, the National Institutes of Health (NIH) issued a media advisory announcing the results of a proof-of-concept identifying three antibodies that protect against various human immunodeficiency virus (HIV) strains. The study results were published in an article by Science Translational Medicine. Led by investigators at the Vaccine...

Read More


More Articles

Newly Approved Monoclonal Antibody Prevents RSV in Babies and Toddlers

by Veronica Salib

On July 17, 2023, the FDA added to the arsenal of respiratory syncytial virus (RSV) prevention tools by approving Beyfortus, a monoclonal antibody for preventing the infection in children two years old...

FDA Provides Guidance for Preventing Contamination in Tattoo Ink

by Veronica Salib

On June 12, 2023, United States Food and Drug Administration officials provided guidance for reducing microbial contamination in tattoo ink. The draft recommendation, now open for public commentary,...

FDA-Approved Cell Therapy Protects Patients After Stem Cell Transplant

by Veronica Salib

The FDA recently approved Omisirge (omidubicel-onlv), a new cell therapy meant to protect patients with blood cancer after a stem cell transplant. According to the press release, the treatment can...

RSV, How Pharmacists Can Help Patients Prevent and Manage Infections

by Alivia Kaylor

As respiratory syncytial virus (RSV), influenza (flu), and COVID-19 cases surge across the United States, pharmacists are encouraged to use their advanced healthcare role to educate patients and caregivers about preventing the transmission...

Policy in Practice: How the Influenza Act Would Influence Healthcare

by Veronica Salib

On December 8, 2022, Democratic Representative Rick Larsen introduced the Protecting America from Seasonal and Pandemic Influenza Act of 2022 — referred to as the Influenza Act. Backed by other representatives, clinicians, and public...

Scientists at the University of Washington Study Breast Cancer Vaccine

by Veronica Salib

Early phase studies by scientists at the University of Washington found that a plasmid DNA breast cancer vaccine may produce favorable outcomes, generating anti-tumor immunity. The study, published in...

COVID Vaccines Have Prevented 3,255,656 Deaths

by Veronica Salib

COVID vaccines and vaccination campaigns have had unparalleled benefits throughout the COVID-19 pandemic. Many argue that vaccines have been the most effective public health tool against infection....

Wound Infiltration May Reduce Pain Following Cesarean Delivery

by Veronica Salib

In an article published in JAMA Network Open by Gali Garmi, MD, and his colleagues state that cesarean delivery — commonly referred to as a C-section — is the most common abdominal surgery...

Fourth COVID Shot Reduced the Risk of Infection by 12.9%

by Veronica Salib

While the general public may feel we are post-pandemic, healthcare workers know that COVID still runs rampant worldwide, especially in hospital settings. The recent study published in JAMA Network Open...

Decibel Therapeutics Announces Results of DB-020 Clinical Trial

by Veronica Salib

At the end of June, Decibel Therapeutics announced success in the phase 1b clinical trials on DB-020 for cancer patients receiving cisplatin chemotherapy. DB-020 is a sodium thiosulfate (STS) drug...

USPTF Updates Recommendations on Supplements to Prevent Cancer

by Veronica Salib

The Journal of the American Medical Association recently published an updated recommendation from the USTPF on using vitamins and supplements to prevent cardiovascular disease and cancer. The study...

Vivalink’s Biometrics Data Platform Monitors Oncology Patients

by Samantha McGrail

Digital healthcare solutions company, Vivalink, will provide its Biometric Data Platform to help detect neutropenic fever events in oncology patients.   Vivalink is at the forefront of...

What the New Coronavirus Means for the Pharmaceutical Industry

by Emily Sokol, MPH

A novel strain of the coronavirus has the world scrambling to avoid a global pandemic. In December 2019, the new virus emerged in Wuhan, China. Similar to the severe acute respiratory syndrome (SARS)...

National Diabetes Prevention Program Expands to Pharmacies

by Emily Sokol, MPH

The American Pharmacists Association (APhA) Foundation announced a partnership with Tabula Rasa HealthCare (TRHC) that will scale the National Diabetes Prevention Program to pharmacies across the...

Recent Articles